| |
|
Accenture characterizes the "New Normal" in pharma sales/marketing
More emphasis on digital technologies and overall cost reduction are on the wish list
|
 |
|
A Conversation with Nitin Sahney, Omnicare Specialty Care Group
Since the 1990s, Omnicare (Cincinnati) has been one of the leading pharmacy supply services to the long-term care (LTC) market.
|
 |
|
Serialization and traceability inches closer to reality
Manufacturers are committing capital dollars to packaging-line enhancements; but will the rest of the supply chain be ready by 2015?
|
 |
|
A conversation with Lynnette Cooke, Kantar Health
Kantar Health, a leading global healthcare advisory and market research firm, brought together in 2009 four distinct companies from the life sciences industry
|
 |
|
Life sciences clusters: the emerging markets trend
Annual Jones Lang LaSalle report ranks US clusters, looks at international activity
|
 |
|
Stakeholder survey finds broad approval for copay cards
Patients, physicians and pharmacists signal their support of copay cards in Alliance Life Sciences study
|
|
Vision 2020: evolving markets, evolving business models
PwC's annual analysis sees bright spots in R&D practices, while global economic troubles will constrain healthcare spending
|
|
Medication errors from injectable drugs are a $2.7-5.1-billion problem for US hospitals
Peer-reviewed study correlates adverse drug events (ADEs) with form of drug administration; can pharma manufacturers help?
|
 |
|
Medication non-adherence is a $188-billion revenue gap for pharma, says Capgemini
New study magnifies the lost opportunity for industry eighteen-fold; the global gap is $564 billion
|
|
Getting ready for health exchanges - or not
The new insurance exchanges are bound to impact industry rebates - and therefore the ability to manage financial reporting, says PwC Health Research Institute
|
|
|
|
|
